Martin Bornhauser

Featured in: Favicon

nature.com Favicon

frontiersin.org Favicon

jamanetwork.com Favicon

msard-journal.com Favicon

onlinelibrary.wiley.com Favicon

Articles

The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers - Cell Death & Differentiation

Mar 26, 2025 | nature.com | Vida Kufrin |Silvia Schäfer |Frank Buchholz |Martin Bornhauser |Marius Bill

AbstractLysine acetyltransferase 2 A (KAT2A) plays a pivotal role in epigenetic gene regulation across various types of cancer. In colorectal cancer (CRC), increased KAT2A expression is associated with a more aggressive phenotype. Our study aims to elucidate the molecular underpinnings of KAT2A dependency in CRC and assess the consequences of KAT2A depletion.
Continuously improving outcome over time after second allogeneic stem cell transplantation in relapsed acute myeloid leukemia: an EBMT registry analysis of 1540 patients | Blood Cancer Journal

May 1, 2024 | nature.com | Ali Bazarbachi |Jürgen Finke |Nicolaus Kröger |Martin Bornhauser |Friedrich Stölzel |Peter Dreger | +4 more

AbstractSecond allogeneic stem cell transplantation (alloSCT2) is among the most effective treatments for acute myeloid leukemia (AML) relapse after first alloSCT (alloSCT1). Long-term EBMT registry data were used to provide large scale, up-to-date outcome results and to identify factors for improved outcome.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →